
Description CBio Limited engages in the research and development of pharmaceutical products for the treatment of autoimmune and inflammatory diseases primarily in Australia. Its products include XToll, a drug therapy that has completed Phase IIa clinical trials for the treatment of human autoimmune diseases, including rheumatoid arthritis. The company was founded in 2000 and is headquartered in Seventeen Mile Rocks, Australia. To view the detailed information, you need to SUBSCRIBE with us. |
![]() |